Log in to save to my catalogue

Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19

Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7464057

Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19

About this item

Full title

Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19

Publisher

London: Nature Publishing Group UK

Journal title

Signal transduction and targeted therapy, 2020-09, Vol.5 (1), p.180-180, Article 180

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

COVID-19 patients exhibit differential disease severity after SARS-CoV-2 infection. It is currently unknown as to the correlation between the magnitude of neutralizing antibody (NAb) responses and the disease severity in COVID-19 patients. In a cohort of 59 recovered patients with disease severity including severe, moderate, mild, and asymptomatic,...

Alternative Titles

Full title

Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7464057

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7464057

Other Identifiers

ISSN

2059-3635,2095-9907

E-ISSN

2059-3635

DOI

10.1038/s41392-020-00301-9

How to access this item